Calcipotriol/niacinamide

Drug Profile

Calcipotriol/niacinamide

Alternative Names: Calcipotriol/nicotinamide; DPS-101

Latest Information Update: 02 Sep 2015

Price : $50

At a glance

  • Originator Dermipsor
  • Class Antipsoriatics; Cyclohexanes; Indenes; Nicotinic-acids; Nonsteroidal anti-inflammatories; Small molecules; Vitamin D analogues; Vitamins
  • Mechanism of Action Calcitriol receptor agonists; Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Plaque psoriasis

Most Recent Events

  • 28 Oct 2008 Safety and efficacy data from a phase IIb trial in Plaque psoriasis released by Dermipsor
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top